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ABSTRACT 
 
Incidence of kidney failure is on the increase, unfortunately, traditional renal function markers are equivocal especially at the 
early stage until end-stage renal disease when kidney transplant becomes inevitable. Hence, the need for early and more sensitive 
marker of renal damage indicating the presence of covert renal damage in occupational lead toxicity is imperative. This work is 
proposing diagnostic methods that could predict the development of Chronic Renal Failure (CRF) especially in occupational 
lead-exposed subjects combining results of conventional and new biomarkers of kidney damage using a mathematical model 
based on Area under the Receiver Operating Characteristics (AUROC). Traditional Renal Function markers (TRF) (plasma 
creatinine, urea and uric acid) were determined in one hundred each of Lead Exposed Subjects (LES) and non-exposed, non-
nephrotic adults (control) along with sixty Chronic Renal Failure patients (CRF) (all age-matched) using standard 
spectrophotometric methods. Blood lead level (Pb) was determined in all participants using Atomic Absorption 
Spectrophotometry (AAS) while levels of novel urinary renal enzymes - Glutathione-S-transferase (GST) and N-acetyl-β-D-
glucosaminidase (NAG)- activities were also evaluated using ELISA techniques. Pb was used as True Positive Indices (TPI) and 
TRF along with NAG and GST were used as False Negative Indices (FNI). Ratios of mean, Creatinine: GST (A) (0.01, 0.02 and 
0.09), Creatinine:NAG (B) (0.03, 0.08 and 0.6), Uric acid:GST (C) (0.05, 0.08 and 0.08), Uric acid:NAG (D) (0.29, 0.3 and 
0.55), Urea:GST (E) (0.17, 0.55 and 0.93), Lead:GST (F) (0.42, 0.59 and 0.88), Lead:NAG (G) (2.56, 2.28 and 6.09), 
Lead:Creatinine (H) (80.62, 30.37 and 10.22), Lead:Urea (I) (2.46, 1.07 and 0.95) and Lead:Uric acid (J) (8.66, 7.61 and 11.12) 
for LES, control and CRF groups respectively were computed and used to plot an ROC curve using the FNI values as the abscissa 
and the TPI values as the ordinate while their AUC were calculated. The AUC values for Lead:Creatinine, Lead:Urea and 
Lead:Uric acid were 1.00, 0.917 and 0.833 respectively. It is suggested that application of this model after proper standardization 
may be useful in early identification of covert kidney damage especially in occupationally vulnerable group  
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INTRODUCTION 
 
Lead has been known as an environmental contaminant for 
several years (Hippocrates in 1841). There have been many 
reports on its toxic effect on virtually every human system; its 
effect on the renal system has been among those that have 
been extensively studied (Markowitz, 2000). In spite of all 
these and the advancement of medical science even in the 
developed economies, establishing lead toxicity in the kidney 
at the early stage to prevent the problem of kidney replacement 
remains a medical challenge (Edward Lock 2010). Several 
hypotheses on identifying an early sensitive biological marker 
of lead toxicity have been equivocal (Poonam and Farhat, 
2005; Weeden et al, 1975). Several biomarkers of exposure, 
effect and susceptibility have been proposed, however, 
problems of sensitivity and specificity especially in cases of 
continuous low dose exposure characteristic of occupational 
lead exposure remains a challenge. Blood lead level remains 
the most promising as a biomarker of exposure which will 
directly reveal the level of the causative agent of toxicity 
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(Lock, 2010; Sakai, 2000). However, as promising as this is, 
the set-backs associated with lead estimation as an index of 
toxicity which include problems with its estimation and 
inability to reflect the overall body burden remain issues of 
importance in its use. Also, the innocuous damage it causes at 
even sub-lethal doses has made fixing a definite safe reference 
value a big problem in its application as the gold standard for 
lead toxicity.  In spite of all these draw backs, estimation of 
blood lead level remains the most plausible gold standard in 
the diagnosis of lead poisoning including lead nephropathy. 
The use of urinary enzymes (NAG and GST) as disease 
markers is well established (Khalil Manesh et al, 1994; Mutti 
1989); again, their genetic susceptibility in their use as 
differential markers for early kidney damage has cast some 
shadows on their acceptability as reliable markers of kidney 
damage. Other markers like urinary copro/uroporphyrin, the 
traditional renal function markers (plasma creatinine, urea and 
uric acid) (El Saleh, 1993) and even application of Kidney 
Injury Molecule (KIM) protein are either overtly sensitive or 
non-specific to be totally reliable (Boventre, 2009). A number 
of inconsistencies have also been reported as to the universal 
applicability of single tests in establishing early kidney 
disease (Siew et al, 2011). Hence, the need for a paradigm 
shift towards developing a diagnostic model that may address 
this problem.  
 Area Under the Receiver Operating Characteristic Curve 
(AUROC) is a well-known measure of ranking performance, 
estimating the probability that a random positive is ranked 
before a random negative.  It is also often used as a measure 
of aggregated classiﬁcation performance, on the grounds that 
AUC in some sense averages over all possible decision 
thresholds (Flach et al, 2011). Receiver-operating 
characteristic (ROC) analysis was originally developed during 
World War II to analyse classification accuracy in 
differentiating signal from noise in radar detection (Lusted, 
1971). Recently, the methodology has been adapted to several 
clinical areas heavily dependent on screening and diagnostic 
tests (Zhou, Obuchowski and McClish, 2002; Pepe, 2003). In 
particular, ROC analysis has been applied in laboratory testing 
(Campbell, 1994), epidemiology (Shapiro, 1999), radiology 
(Obuchwski, 2003) and bioinformatics (Lasko et al, 2005). 
ROC analysis is a useful tool for evaluating the performance 
of diagnostic tests and more generally for evaluating the 
accuracy of a statistical model (e.g., logistic regression, linear 
discriminant analysis) that classifies subjects into 1 of 2 
categories, diseased or non-diseased. Its function as a simple 
graphical tool for displaying the accuracy of a medical 
diagnostic test is one of the most well-known applications. 
Over the years, application of ROC analysis in evaluating 
performance of diagnostic tests towards classifying subjects 
into two classes of “diseased” and “non-diseased” is not new 
in medical diagnostics (Zou et al, 2007,; Tom Fawcett, 2005). 
This method classically employs the basic rule of sensitivity 
and specificity of a method in accurately predicting the 
outcome of an event. In practise, sensitivity is known to be 
inversely proportional to specificity; thus the method (or 
combination of methods) that gives the highest specificity 
(closest fraction of 1) with a sensitivity appropriately moving 
towards 1 will be the most suitable. It is then mathematically 
chosen as the most likely method (methods) that will clearly 
distinguish diseased from non-diseased state even when other 
results or indicators look apparently normal or contrary (Zou 
et al, 2007).  
 Consideration of this method as an option in identifying 
early kidney disease in lead exposure becomes imperative in 
the absence of a reliable sensitive and specific marker of 
kidney damage especially in occupationally vulnerable group. 
This report is thus proposing a mathematical model based on 
Area Under the Curve of binary results for the various markers 
of lead toxicity using the ROC with significant p-values for 
lead exposed subjects using patients already diagnosed with 
CKD and participants with normal renal function as positive 
and negative controls respectively. The choice of a diagnostic 
method will therefore be determined by an AUC with the 
highest specificity (closest to 1) yet exhibiting very good 
sensitivity 
 
MATERIALS AND METHODS 
 
This study determined levels of both conventional (plasma 
creatinine, urea and uric acid) and new [urinary N-acetyl-β-D- 
glucosaminidase (NAG) and glutathione-S-transferase (GST)] 
kidney function markers  in comparison to the level of 
conventional biomarker of exposure (blood lead- gold 
standard) in occupationally exposed participants (cases), 
established chronic renal failure patients under treatment 
(positive controls) and participants with normal kidney 
function clinically assessed (normal control). Results obtained 
were then computed as binary figures to plot ROC curve the 
area of which were compared and analyzed statistically to 
determine which results or result-combinations gave the best 
in terms of sensitivity and specificity. 
 
Materials 
Participants for this study were recruited in three categories as 
follows: 
 
Normal Control: This group consisted of 50 healthy adults 
(men and women aged 20-50years) with no kidney disease; 
they were civil and public servants in and around the 
University College Hospital, Ibadan, Nigeria. They were 
selected based on clinical and radiological examination and 
also on the biochemical indices of kidney functions which 
were normal in all of them. 
 
Exposed participants: 100 participants (aged 23- 47years) 
consisting of workers in a lead smelting and battery 
manufacturing plant (Associated Battery Manufacturing 
Company (ABM) and ABM Metal Recovery Division based 
in Ikeja, Lagos) were recruited for this group. Others in the 
group were those occupationally exposed to lead like 
automobile-mechanics, battery-repairers, welders, 
vulcanizers, and vehicle-painters. They have all been exposed 
to lead occupationally for periods ranging from 3-7years 
 
Positive controls.: 25 CRF patients (aged 35-65years) 
clinically diagnosed at the medical out-patient department of 
the University College Hospital, Ibadan were recruited for this 
group; 20 of these patients were already slated for renal 
dialysis. 
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Collection of Samples: 10mls of blood was collected from 
each of the above participants into lithium heparin bottles. 
Blood in lithium heparin bottle was divided into two portions; 
the first portion was used for lead analysis. Plasma was 
separated from the second portion and analyzed for plasma 
creatinine, urea and uric acid concentrations, respectively. 
 Random urine specimens were also collected from 
participants in the three groups to be used in the determination 
of urinary microalbumin qualitatively, urinary GST and NAG 
quantitatively.  
 
Analytical Procedures: Blood Lead (Pb) Assay: This was 
done using Atomic Absorption Spectrophotometry based on 
the modified method of Hessel (1968). Blood samples were 
wet digested and analyzed using Buck Scientific Atomic 
Absorption Spectrophotometer Model 210VGP (USA). 
Plasma creatinine concentrations were determined 
spectrophotometrically based on alkaline picrate method of 
Jaffe and Larsen as modified by Bartels (1971). Plasma urea 
was determined spectrophotometrically using the Diacetyl 
monoxide method of Varley (1969). Plasma uric acid was 
estimated spectrophotometrically using the ultra violet 
method of Praetorius et al (1972). N- acetyl- β -D-
glucosaminidase activity was determined using PPR 
Diagnostic NAG kit Manufactured by PPR Diagnostics Ltd, 
England. Urinary Glutamyl-S-Transferase activity was 
determined using Biotrin GST kit (purchased from Biotrin 
International Ltd, Dublin, Ireland). This kit is based on 
Enzyme Immunoassay technique. 
 
The AUROC computation: The above analytical parameters 
were categorized into two main groups, the true positive and 
the false negative groups.                                                                                                                            
The true positive was the marker of exposure which 
undoubtedly was the blood lead (Pb) level; this is the gold 
standard used. The false negative were levels of other 
biomarkers of effect including all the conventional kidney 
function markers (plasma creatinine, urea and uric acid) and 
the new urinary kidney function markers (NAG and GST).  
These results were then paired and compared across the three 
group of participants.  
 The sensitivity of these results (as binary figures) was 
evaluated within the 95% CI. The values obtained were then 
used to plot a ROC curve with the true positive values as the 
ordinate and the false negative values as the abscissa. The 
metrics of this curve is the Area under the curve or the 
AUROC.  
 These AUROC were then subjected to statistical analysis 
using ANOVA and Pearson Correlation to determine their 
sensitivity, specificity and variation towards identifying the 
most suitable biomarker or combination of biomarkers that 
may predict covert kidney damage. 
 
 
RESULTS 
 
Table 1 shows the mean result of lead: 23.4±9.7µg/100ml, 
31.7±7.7µg/100ml and 89.9±13.9 µg/100ml in controls, cases 
and CRF participants respectively (Fig. 1).  
 
 
Figure 1 
Blood lead levels in control, Chronic Renal Failure (CRF) and Lead 
exposed (LES) participants.  
 
Table 1:   
Creatinine, uric acid, Urea, urinary NAG and GST 
concentrations in the 3 groups of subjects studied 
 Control LES CRF 
Plasma Creatinine 
(mg/100ml) 
0.77±0.39 0.39±0.45 8.79±5.20 
Plasma Uric/Acid 
(mg/100ml)   
3.08±1.10 3.66±1.80 8.08±3.80 
Urinary GST (µg/L)   39.47±25.90 75.91±27.70                                                                                               102.16±54.50
Urinary NAG (IU/L 10.26±1.75 12.39±3.81   14.77±6.27 
Plasma Urea 
(mg/100ml) 
21.88±5.03 12.90±7.95 94.91±43.87 
 
Table 2. 
Descriptive ratios of Pb blood Pb, plasma creatinine, plasma 
uric acid, plasma urea, urinary NAG and GST concentrations 
in the 3 groups of subjects studied 
Test Result 
Variable(s) 
Area S.Ea Asymptotic 
Sig.b 
Asymptotic 95% 
Conf. Interval 
    Lower 
bound 
Upper  
bound 
Creat_GST .000 .000 0.004 .000 .000  
Creat_NAG .000 .000 0.004 .000 .000 
Creat_Pb .000 .000 0.004 .000 .000 
UricA_GST .104 .082 .021 .000 .265 
UricA_NAG .146 .096 .039 .000 .334 
UricA_Pb .146 .099 .039 .000 .339 
Urea_GST .063 .065 .011 .000 .190 
Urea_NAG .083 .080 .015 .000 .240 
Urea_Pb .083 .148 .015 .000 .240 
Pb_GST .604 .121 .544 .313 .895 
Pb_NAG .750 .099 .146 .512 .988 
Pb_UricA .854 .000 .039 .661 1.000 
Pb_Creat 1.00 .080 .004 1.000 1.000 
Pb_Urea .917  .015 .760 1.000 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5  
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Figure 2:  
ROC Curve showing sensitivity, specificity and variation of biomarkers of kidney damage in the three groups of participants 
 
 
The blood lead level in cases may be said to have indicated 
lead as the biomarker of exposure and as a true positive 
indicator of exposure to this toxic metal in these 
occupationally exposed participants. 
 Results of plasma creatinine (0.8, 0.4 and 8.8mg/100ml), 
urea (21.9, 12.9 and 94.9mg/100ml) and uric acid (3.1, 3.7 and 
8.1mg/100ml) respectively in controls, cases and CRF 
participants also indicated non-concomitant elevation in these 
biomarkers of effect as against values obtained in the 
biomarker of exposure. This underscores these biomarkers as 
possible false negative indicators of exposure. 
 Results of urinary markers NAG (10.3U/L,12.4U/L and 
14.8U/L) and GST (3.9ug/L, 75.9ug/L and 102.2ug/L) in 
control, cases and in CRF participants were equally not clearly 
indicative as biomarkers of effect in establishing covert lead 
toxicity in the exposed participants. 
 Table 2 shows the calculated Mean area of the ratios, their 
standard error and significance along with their lower and 
upper limits. The closer the figure was to 1 (one), the greater 
its positivity and hence the possibility of its application as a 
biomarker and prognostic value in predicting development of 
CRF in the subjects especially in those occupationally 
exposed to Pb. 
 
DISCUSSION 
 
Lead nephropathy is one of the diseases associated with lead   
toxicity, mortality due to this condition is largely due to the 
derangement in kidney function especially at the tubular level 
where the normal tubular secretion and reabsorption of 
substances is impaired. As old as the problem of lead toxicity 
is and in as much as there are many research publications on 
the medical problem, identifying covert lead toxicity at the 
early stage to allow for necessary intervention remains a 
medical problem. This work thus set out to investigate whether 
biomarker of exposure (blood lead level) actually correlated 
with biomarker of effects [conventional and novel (urinary) 
kidney function markers] especially at the early stage in 
occupationally exposed subjects and design a mathematical 
model that can predict advent of this problem before a 
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permanent damage is done. The need for a mathematical 
model was informed not only by the diffuse nature of the 
problem but also by current trends in biochemical research 
whereby emphasis is now on in-silico rather than on animal 
models in research.   
 In this study, in spite of long term of exposure to the toxic 
metal (Pb) as aptly demonstrated by increased level of 
biomarker of exposure (Pb) observed in cases, presence of 
insidious damage to the kidney by a concomitant increase in 
the level of biomarker of effect (plasma creatinine, urea and 
uric acid) levels was not shown. Levels of biomarkers of effect 
monitored in the exposed participants were all normal except 
for level of the urinary enzyme, GST, which was raised. The 
non-concomitant increase in levels of biomarker of effect in 
lead exposed participants in this study is the general picture 
peculiar to most people occupationally exposed to low 
continuous dose of lead (like in lead smelters, welders, 
vulcanizers etc). Hence, the insidious damage to the kidney 
due to the continuous exposure may remain unnoticed till end 
stage renal disease when irreversible damage of the kidney 
would have occurred. That this insidious damage to the kidney 
remain unnoticed may not be unconnected with the large 
reserve capacity of the kidney informed by the large number 
of nephrons constituting the kidney (Flora et al, 2012). It’s 
been severally reported that clinical and biochemical 
symptoms of kidney damage may not manifest until more  
than 60% of the nephrons is destroyed (Flora et al, 2012), 
hence, effect of exposure to the toxic metal (Pb) may not 
manifest in the biomarkers of effect as seen in this study until 
a gross damage has occurred in the kidney. This was clearly 
demonstrated in all the CRF cases where levels of biomarkers 
of effect determined in the group were all abnormally high. In 
contrast to this, there was no corresponding or equivalent 
increase between the biomarker of exposure (Pb) and 
biomarkers of effect [true renal failure (TRF)], even the 
observed increase in urinary GST was not commensurate with 
the level and years of exposure to the nephrotoxin (Pb). The 
equally prognostic saturnine gout symptomatic of long 
exposure to Pb was also not seen in exposed participants in 
this study. 
 It was this diffuse picture of chronic exposure to Pb which 
was not equivalently reflected in the biomarker of effects 
(conventional and novel kidney damage indicators) that 
prompted the need to look for a mathematical model that may 
solve the riddles of early and sensitive diagnosis of lead 
nephropathy. Thus, Area Under the Receiver Operating Curve 
(AUROC) was investigated as a possible mathematical tool.   
 The area under the ROC curve (AUC) is a well-known 
measure of ranking performance, estimating the probability 
that a random positive is ranked before a random negative, 
without committing to a decision threshold. It is also often 
used as a measure of aggregated classiﬁcation performance, 
on the grounds that AUC in some sense averages over all 
possible decision thresholds that would not only identify a 
more selective and specific biomarker but would also be 
prognostic of progression to end stage renal disease. The 
veracity of ROC as a tool for verifying a method and in 
predicting an event lies on the ability to make a binary 
prediction which can be in 4 different outcomes (Metz,1978): 
(a) A True Negative, i.e. this correctly predict that the class is 
negative (0.0) (b: A False Negative, i.e. this incorrectly predict 
that the class is negative (c): A False Positive, i.e. we 
incorrectly predict that the class is positive (d): A True 
Positive, i.e. we correctly predict that the class is positive 
(1.0).  
 Hence, combining levels of biomarker of exposure (Pb) 
with those of effects (TRF) and expressing the binomial values 
of these as coordinates on the ROC revealed a distinct profile 
of the relationship between the two sets of biomarkers. The 
distinct picture was better seen in the combination of Pb vs 
Creatinine, Pb vs Urea and Pb vs Uric acid in comparison to 
the combination of Pb vs GST and Pb vs NAG. Hence, the 
calculated AUROC was closer to the true value of 1.0 in the 
earlier combination than the latter. It may be inferred that 
combining the values by expressing levels of biomarker of 
exposure (Pb) as the ratio of TRF as stated above may be 
similar to determining the clearance/excretory rate of Pb 
relative to those of TRF. 
 Therefore, the relatively better prognostic picture of 
kidney damage as seen in the higher AUROC values of Pb vs 
TRF in comparison to those of urinary enzyme markers may 
be indicative of the insidious damage which ordinarily would 
not be noticed until a later stage of continuous exposure to the 
nephrotoxin (Pb). At that stage, the damage would have 
become irreversible.  
 Mathematically, for a ratio (x/y) to be tending towards 
1.0, the denominator (y) must be on the increase almost in the 
same proportion with the nominator. Hence physiologically, a 
hypothetic situation will be reached where the rate of 
accumulation of x (which in this instance is the biomarker of 
exposure (Pb) would have precipitated so much of the TRF 
(biomarker of effect) to the extent of the ratio reaching the true 
value of 1.0. The lower ratios of AUROC of Pb vs NAG and 
GST may thus indicate a better clearance/excretory rate of Pb 
relative to those of the TRF in chronic Pb exposure. In acute 
exposure, the levels of urinary NAG and GST will be high 
enough to be prognostic of acute renal failure which may be 
due to secretion of the two enzymes (directly in the renal 
tubular cells) (Wiland et al, 1997) and their faster rate of 
clearance (tubular excretion) as different from the TRF which 
are more indicative of renal glomerular function (Bulent et al, 
2016).  
 In conclusion, a mathematical model expressing levels of 
Pb (as the biomarker of exposure) against the levels of the 
TRF and calculating the AUROC from the ROC of their 
binomial values may give a better and early prognostic picture 
of the development of chronic kidney failure especially in 
subjects chronically exposed to Pb as in those occupationally 
routinely exposed after proper standardization is hereby 
proposed. Drawing up of a normogram based on this model 
may also be a plausible approach to applying this model.. 
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